Pfizer, BioNTech start late stage clinical trial of Covid-19 vaccine
New York: US-based Pfizer and German biotech firm BioNTech have announced the start of a late stage clinical trial of a Covid-19 vaccine jointly developed by the two companies.
The Phase 2/3 study will involve up to 30,000 participants…
Read More...
Read More...